ALNYALNYLAM PHARMACEUTICALS, INC.
Health Care
Stockholders' Equity Attributable to Parent revised up 269.2% for Q3 2025
Stockholders' Equity Attributable to Parent·As of Mar 31, 2025
Major restatement$426.1M▲ 269.2%
was$115.4M
Revised up in a 10-Q.
Verify against SEC filingsShow
As reported$115.4M
Accepted 2025-05-010001178670-25-000052
Restated$426.1M
Accepted 2026-10-290001178670-26-000076
StockholdersEquity · reported 5 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time ALNY — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.